药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Hydralazine
Vilanterol
The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Crizotinib.
Hydralazine
Olodaterol
The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Crizotinib.
Hydralazine
Flumequine
The risk or severity of QTc prolongation can be increased when Flumequine is combined with Crizotinib.
Hydralazine
Indenolol
The risk or severity of QTc prolongation can be increased when Indenolol is combined with Crizotinib.
Hydralazine
Chlorcyclizine
The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Crizotinib.
Hydralazine
Eribulin
The risk or severity of QTc prolongation can be increased when Eribulin is combined with Crizotinib.
Hydralazine
Bupranolol
The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Crizotinib.
Hydralazine
Geranylgeranyl diphosphate
The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Crizotinib.
Hydralazine
Farnesyl diphosphate
The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Crizotinib.
Hydralazine
Triptorelin
The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Crizotinib.
Hydralazine
Histrelin
The risk or severity of QTc prolongation can be increased when Histrelin is combined with Crizotinib.
Hydralazine
Buserelin
The risk or severity of QTc prolongation can be increased when Buserelin is combined with Crizotinib.
Hydralazine
Degarelix
The risk or severity of QTc prolongation can be increased when Degarelix is combined with Crizotinib.
Hydralazine
Cariporide
The risk or severity of QTc prolongation can be increased when Cariporide is combined with Crizotinib.
Hydralazine
Amisulpride
The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Crizotinib.
Hydralazine
Vernakalant
The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Crizotinib.
Hydralazine
Tandutinib
The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Crizotinib.
Hydralazine
Methsuximide
The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Crizotinib.
Hydralazine
Ezogabine
The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Crizotinib.
Hydralazine
Farnesyl thiopyrophosphate
The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Crizotinib.